

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 6.10102167 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 6.00494911 |
| 3 | regulation of platelet aggregation (GO:0090330) | 5.41552285 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.98349044 |
| 5 | regulation of chemokine secretion (GO:0090196) | 4.93018812 |
| 6 | regulation of platelet activation (GO:0010543) | 4.91259262 |
| 7 | lipoxygenase pathway (GO:0019372) | 4.91103248 |
| 8 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.50029737 |
| 9 | positive regulation of mast cell activation (GO:0033005) | 4.47452065 |
| 10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.42360336 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.41010424 |
| 12 | angiogenesis involved in wound healing (GO:0060055) | 4.38586745 |
| 13 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.31999358 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22517888 |
| 15 | adenosine receptor signaling pathway (GO:0001973) | 4.19994818 |
| 16 | microglial cell activation (GO:0001774) | 4.12561936 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.08150123 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.08150123 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.08150123 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.08150123 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 4.08150123 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 4.08150123 |
| 23 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.95383167 |
| 24 | negative regulation of platelet activation (GO:0010544) | 3.94784937 |
| 25 | cellular extravasation (GO:0045123) | 3.94549637 |
| 26 | negative regulation of granulocyte differentiation (GO:0030853) | 3.91277632 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.85380119 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 3.82825276 |
| 29 | neutrophil activation (GO:0042119) | 3.74992139 |
| 30 | platelet degranulation (GO:0002576) | 3.65518335 |
| 31 | homotypic cell-cell adhesion (GO:0034109) | 3.60637020 |
| 32 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59742347 |
| 33 | response to peptidoglycan (GO:0032494) | 3.59040017 |
| 34 | pinocytosis (GO:0006907) | 3.56340307 |
| 35 | megakaryocyte development (GO:0035855) | 3.55567759 |
| 36 | positive regulation of receptor recycling (GO:0001921) | 3.54846526 |
| 37 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53642565 |
| 38 | apoptotic cell clearance (GO:0043277) | 3.52112680 |
| 39 | granulocyte activation (GO:0036230) | 3.51461265 |
| 40 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.48726107 |
| 41 | extracellular fibril organization (GO:0043206) | 3.46789825 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.45999219 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.45865422 |
| 44 | positive regulation of mast cell degranulation (GO:0043306) | 3.41304296 |
| 45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.41304296 |
| 46 | positive regulation of macrophage differentiation (GO:0045651) | 3.37628355 |
| 47 | endothelium development (GO:0003158) | 3.34843082 |
| 48 | mannose metabolic process (GO:0006013) | 3.32149952 |
| 49 | fibril organization (GO:0097435) | 3.30063800 |
| 50 | keratan sulfate catabolic process (GO:0042340) | 3.28737488 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28048660 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28048660 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.27622144 |
| 54 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.27149682 |
| 55 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.25582813 |
| 56 | desmosome organization (GO:0002934) | 3.25233267 |
| 57 | platelet activation (GO:0030168) | 3.22469998 |
| 58 | leukotriene metabolic process (GO:0006691) | 3.22387840 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.21146858 |
| 60 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.18429362 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.16203284 |
| 62 | negative regulation of interleukin-17 production (GO:0032700) | 3.15593649 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 3.15218345 |
| 64 | positive regulation of hemostasis (GO:1900048) | 3.15218345 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.13858504 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12610473 |
| 67 | * cyclooxygenase pathway (GO:0019371) | 3.11704622 |
| 68 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.09835171 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 3.07610063 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 3.07607526 |
| 71 | macrophage differentiation (GO:0030225) | 3.07046127 |
| 72 | regulation of apoptotic cell clearance (GO:2000425) | 3.04799426 |
| 73 | protein neddylation (GO:0045116) | 3.03881289 |
| 74 | hyaluronan catabolic process (GO:0030214) | 3.03661388 |
| 75 | macrophage activation (GO:0042116) | 3.02951594 |
| 76 | response to fungus (GO:0009620) | 3.00210367 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99957694 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99445275 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 2.99160799 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 2.98718823 |
| 81 | membrane invagination (GO:0010324) | 2.98352209 |
| 82 | definitive hemopoiesis (GO:0060216) | 2.97779649 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96639404 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95422440 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.94635763 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.94635763 |
| 87 | positive regulation of coagulation (GO:0050820) | 2.90410403 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.90320390 |
| 89 | platelet formation (GO:0030220) | 2.89609675 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88917839 |
| 91 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.88218478 |
| 92 | negative regulation of interleukin-8 production (GO:0032717) | 2.87080486 |
| 93 | negative regulation of stress fiber assembly (GO:0051497) | 2.87042293 |
| 94 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.86070675 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84825760 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84222932 |
| 97 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84183565 |
| 98 | peptide catabolic process (GO:0043171) | 2.83750079 |
| 99 | germ cell migration (GO:0008354) | 2.81165470 |
| 100 | response to host (GO:0075136) | 2.79873052 |
| 101 | response to host defenses (GO:0052200) | 2.79873052 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79873052 |
| 103 | hypotonic response (GO:0006971) | 2.79101321 |
| 104 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78212277 |
| 105 | response to host immune response (GO:0052572) | 2.78212277 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.76965234 |
| 107 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76830137 |
| 108 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75441389 |
| 109 | surfactant homeostasis (GO:0043129) | 2.73704629 |
| 110 | regulation of integrin activation (GO:0033623) | 2.73644366 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 2.73601617 |
| 112 | negative regulation of norepinephrine secretion (GO:0010700) | 2.73489466 |
| 113 | ceramide catabolic process (GO:0046514) | 2.72157772 |
| 114 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.72020931 |
| 115 | respiratory burst (GO:0045730) | 2.71909164 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.69376299 |
| 117 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.69345113 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 2.69338495 |
| 119 | leukocyte degranulation (GO:0043299) | 2.68832083 |
| 120 | response to interferon-alpha (GO:0035455) | 2.67009529 |
| 121 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.66182848 |
| 122 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65944250 |
| 123 | sodium-independent organic anion transport (GO:0043252) | 2.65941849 |
| 124 | phagocytosis, engulfment (GO:0006911) | 2.65551356 |
| 125 | skin morphogenesis (GO:0043589) | 2.65512486 |
| 126 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.64271470 |
| 127 | detection of other organism (GO:0098543) | 2.61096036 |
| 128 | regulation of blood coagulation (GO:0030193) | 2.61037354 |
| 129 | regulation of hemostasis (GO:1900046) | 2.61037354 |
| 130 | glycosphingolipid catabolic process (GO:0046479) | 2.60231757 |
| 131 | leukotriene biosynthetic process (GO:0019370) | 2.60094824 |
| 132 | negative regulation of focal adhesion assembly (GO:0051895) | 2.60077220 |
| 133 | negative regulation of cell junction assembly (GO:1901889) | 2.60077220 |
| 134 | negative regulation of adherens junction organization (GO:1903392) | 2.60077220 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58820970 |
| 136 | regulation of phagocytosis (GO:0050764) | 2.58261245 |
| 137 | regulation of macrophage chemotaxis (GO:0010758) | 2.57599842 |
| 138 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.57574333 |
| 139 | stress fiber assembly (GO:0043149) | 2.56766647 |
| 140 | purinergic receptor signaling pathway (GO:0035587) | 2.56248219 |
| 141 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55838671 |
| 142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55241300 |
| 143 | negative regulation of cell killing (GO:0031342) | 2.55241300 |
| 144 | regulation of interleukin-17 production (GO:0032660) | 2.52831241 |
| 145 | hemidesmosome assembly (GO:0031581) | 2.52418957 |
| 146 | gland morphogenesis (GO:0022612) | 2.52151044 |
| 147 | germinal center formation (GO:0002467) | 2.52143189 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52129197 |
| 149 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.51697951 |
| 150 | detection of external biotic stimulus (GO:0098581) | 2.51275721 |
| 151 | negative regulation of interleukin-12 production (GO:0032695) | 2.50963939 |
| 152 | regulation of interleukin-8 secretion (GO:2000482) | 2.50807515 |
| 153 | autophagic vacuole fusion (GO:0000046) | 2.50621117 |
| 154 | * arachidonic acid metabolic process (GO:0019369) | 2.49308820 |
| 155 | macrophage chemotaxis (GO:0048246) | 2.49078624 |
| 156 | negative regulation of phagocytosis (GO:0050765) | 2.48262646 |
| 157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.46298318 |
| 158 | negative regulation of bone mineralization (GO:0030502) | 2.44603273 |
| 159 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.43344090 |
| 160 | positive regulation of phagocytosis (GO:0050766) | 2.43129729 |
| 161 | immunoglobulin mediated immune response (GO:0016064) | 2.42969380 |
| 162 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.42915343 |
| 163 | response to fluid shear stress (GO:0034405) | 2.37903017 |
| 164 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.36276583 |
| 165 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.35938016 |
| 166 | platelet aggregation (GO:0070527) | 2.34621903 |
| 167 | hepatocyte apoptotic process (GO:0097284) | 2.34386639 |
| 168 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.32458448 |
| 169 | * icosanoid biosynthetic process (GO:0046456) | 2.32364661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.02353488 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.55845078 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78112593 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.42599409 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29398579 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.13324637 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12900350 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12532813 |
| 9 | GATA1_19941826_ChIP-Seq_K562_Human | 2.97291123 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.93451553 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92252729 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90680574 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79064474 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70512021 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.64689466 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51494805 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.47862080 |
| 18 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.46523559 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44149943 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40092571 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08098762 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06441761 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04147670 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93008251 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91662428 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.91274154 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88348983 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86782859 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85099284 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83054606 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80901127 |
| 32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.76863764 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76790394 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76660775 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73821131 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66655990 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63936012 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63005865 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62820532 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61989896 |
| 41 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59896775 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55808063 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53595840 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53595840 |
| 45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51707891 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51256641 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50550705 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48334572 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47908179 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47400184 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44149606 |
| 52 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.43104807 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41821060 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.41685887 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40234050 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40078626 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.39049466 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39029296 |
| 59 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38059965 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36010600 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34904747 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34811507 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33779753 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33233725 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.33022484 |
| 66 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.30456567 |
| 67 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.28966897 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26721278 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25694427 |
| 70 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24616238 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23377793 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23335670 |
| 73 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22952142 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22566712 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20926933 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19992293 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19766623 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18668074 |
| 79 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18386199 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17613930 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17613930 |
| 82 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17523718 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17398499 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17113987 |
| 85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17107319 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16757990 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16292773 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12779017 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12095966 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10564212 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10082315 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10030420 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09980215 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08570882 |
| 95 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08487374 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08152086 |
| 97 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07950635 |
| 98 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07122033 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06739664 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.06106778 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05457279 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05371530 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05117170 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02248205 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02169152 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00025654 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00007625 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98781364 |
| 109 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98359762 |
| 110 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96373154 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95901767 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95807376 |
| 113 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95095357 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95071979 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93152118 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93081489 |
| 117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92229188 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 0.91725955 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90219561 |
| 120 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88189196 |
| 121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.87628491 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87351442 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86654142 |
| 124 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84069145 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83298782 |
| 126 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.82425857 |
| 127 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79930969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.04800624 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.97638087 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 2.67899486 |
| 4 | MP0003724_increased_susceptibility_to | 2.62704567 |
| 5 | MP0003303_peritoneal_inflammation | 2.56223588 |
| 6 | MP0004510_myositis | 2.56096687 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.44954156 |
| 8 | * MP0003436_decreased_susceptibility_to | 2.43301586 |
| 9 | * MP0005464_abnormal_platelet_physiology | 2.43159499 |
| 10 | MP0005275_abnormal_skin_tensile | 2.38755832 |
| 11 | MP0006082_CNS_inflammation | 2.32409357 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.30760572 |
| 13 | MP0002419_abnormal_innate_immunity | 2.30688810 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.29611927 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.16297427 |
| 16 | MP0002796_impaired_skin_barrier | 2.08509059 |
| 17 | MP0004947_skin_inflammation | 1.98412360 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.96249234 |
| 19 | * MP0001533_abnormal_skeleton_physiology | 1.95529765 |
| 20 | MP0005025_abnormal_response_to | 1.93066476 |
| 21 | MP0009785_altered_susceptibility_to | 1.83039721 |
| 22 | MP0006054_spinal_hemorrhage | 1.80962664 |
| 23 | MP0000343_altered_response_to | 1.78826505 |
| 24 | MP0003075_altered_response_to | 1.78758337 |
| 25 | * MP0005000_abnormal_immune_tolerance | 1.75348994 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.74093450 |
| 27 | MP0005671_abnormal_response_to | 1.74067099 |
| 28 | MP0002060_abnormal_skin_morphology | 1.73830894 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.72456036 |
| 30 | MP0000685_abnormal_immune_system | 1.67986831 |
| 31 | * MP0005023_abnormal_wound_healing | 1.67410495 |
| 32 | MP0001851_eye_inflammation | 1.64422190 |
| 33 | MP0003279_aneurysm | 1.63929059 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.62997091 |
| 35 | MP0001958_emphysema | 1.62099813 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.57888587 |
| 37 | MP0009840_abnormal_foam_cell | 1.52262210 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.51924303 |
| 39 | MP0002723_abnormal_immune_serum | 1.51408244 |
| 40 | MP0001800_abnormal_humoral_immune | 1.50783868 |
| 41 | MP0005387_immune_system_phenotype | 1.49405453 |
| 42 | MP0001790_abnormal_immune_system | 1.49405453 |
| 43 | MP0001819_abnormal_immune_cell | 1.47211083 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.46584537 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.46152835 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.46001412 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.45857016 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.45728355 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.41925645 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.41925645 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.38517865 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.38185078 |
| 53 | * MP0001845_abnormal_inflammatory_respons | 1.37990874 |
| 54 | MP0002405_respiratory_system_inflammati | 1.37734354 |
| 55 | MP0005083_abnormal_biliary_tract | 1.37667149 |
| 56 | MP0009278_abnormal_bone_marrow | 1.36837471 |
| 57 | MP0001853_heart_inflammation | 1.32308956 |
| 58 | * MP0001216_abnormal_epidermal_layer | 1.31914368 |
| 59 | MP0002933_joint_inflammation | 1.30493987 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.28208218 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.27055824 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.26952291 |
| 63 | MP0005501_abnormal_skin_physiology | 1.26701862 |
| 64 | MP0004272_abnormal_basement_membrane | 1.26584946 |
| 65 | MP0003941_abnormal_skin_development | 1.22825711 |
| 66 | * MP0010155_abnormal_intestine_physiology | 1.22229507 |
| 67 | MP0008469_abnormal_protein_level | 1.21534815 |
| 68 | * MP0005390_skeleton_phenotype | 1.21402372 |
| 69 | MP0002254_reproductive_system_inflammat | 1.17916328 |
| 70 | MP0003828_pulmonary_edema | 1.17545591 |
| 71 | MP0005166_decreased_susceptibility_to | 1.16907414 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.15810305 |
| 73 | MP0001542_abnormal_bone_strength | 1.15791338 |
| 74 | MP0008260_abnormal_autophagy | 1.15350708 |
| 75 | MP0000249_abnormal_blood_vessel | 1.13242571 |
| 76 | MP0001663_abnormal_digestive_system | 1.13208044 |
| 77 | MP0002132_abnormal_respiratory_system | 1.10507259 |
| 78 | * MP0000230_abnormal_systemic_arterial | 1.09273450 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.08095718 |
| 80 | MP0003091_abnormal_cell_migration | 1.03935217 |
| 81 | MP0003045_fibrosis | 1.03274904 |
| 82 | MP0005503_abnormal_tendon_morphology | 1.01410396 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.01299224 |
| 84 | MP0004036_abnormal_muscle_relaxation | 1.01253842 |
| 85 | MP0005164_abnormal_response_to | 1.00944324 |
| 86 | MP0000716_abnormal_immune_system | 0.99834040 |
| 87 | MP0002006_tumorigenesis | 0.99054672 |
| 88 | MP0005595_abnormal_vascular_smooth | 0.98310253 |
| 89 | MP0001873_stomach_inflammation | 0.97673920 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.97614372 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.97114524 |
| 92 | MP0009764_decreased_sensitivity_to | 0.96991068 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.94933437 |
| 94 | MP0002398_abnormal_bone_marrow | 0.93202913 |
| 95 | MP0001243_abnormal_dermal_layer | 0.92986503 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.91566418 |
| 97 | MP0001191_abnormal_skin_condition | 0.90684412 |
| 98 | MP0005165_increased_susceptibility_to | 0.90384819 |
| 99 | MP0009931_abnormal_skin_appearance | 0.90282103 |
| 100 | MP0003448_altered_tumor_morphology | 0.90183999 |
| 101 | MP0000858_altered_metastatic_potential | 0.89512994 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.89339844 |
| 103 | MP0001879_abnormal_lymphatic_vessel | 0.89177727 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.88613574 |
| 105 | * MP0002722_abnormal_immune_system | 0.88467753 |
| 106 | * MP0000689_abnormal_spleen_morphology | 0.88317133 |
| 107 | MP0003795_abnormal_bone_structure | 0.87729379 |
| 108 | MP0001915_intracranial_hemorrhage | 0.87060215 |
| 109 | MP0002429_abnormal_blood_cell | 0.86357160 |
| 110 | MP0004883_abnormal_blood_vessel | 0.86204772 |
| 111 | * MP0010771_integument_phenotype | 0.84664029 |
| 112 | MP0003866_abnormal_defecation | 0.84083866 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.83078458 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.81759851 |
| 115 | MP0001849_ear_inflammation | 0.79994823 |
| 116 | MP0004130_abnormal_muscle_cell | 0.79174992 |
| 117 | MP0005409_darkened_coat_color | 0.77863327 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.77113029 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.74722493 |
| 120 | * MP0009763_increased_sensitivity_to | 0.73120953 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.72943452 |
| 122 | * MP0000490_abnormal_crypts_of | 0.72691157 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.72685819 |
| 124 | * MP0002128_abnormal_blood_circulation | 0.72277592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 8.26384799 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.88347829 |
| 3 | Glomerulonephritis (HP:0000099) | 4.90073581 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.30290933 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.14691285 |
| 6 | Interstitial pulmonary disease (HP:0006530) | 4.05631787 |
| 7 | Complement deficiency (HP:0004431) | 3.90828245 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.85328177 |
| 9 | Abnormality of complement system (HP:0005339) | 3.82747002 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62756628 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.61942836 |
| 12 | Cerebral aneurysm (HP:0004944) | 3.56521670 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.52187839 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.52187839 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.52187839 |
| 16 | Arterial tortuosity (HP:0005116) | 3.45908495 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.44786861 |
| 18 | Aortic aneurysm (HP:0004942) | 3.43349128 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37362365 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.36631073 |
| 21 | Conjunctival telangiectasia (HP:0000524) | 3.31494836 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.29339527 |
| 23 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.26821953 |
| 24 | Vascular tortuosity (HP:0004948) | 3.20487297 |
| 25 | Nephritis (HP:0000123) | 3.19058987 |
| 26 | Aortic dissection (HP:0002647) | 3.08099433 |
| 27 | Cervical subluxation (HP:0003308) | 3.03914917 |
| 28 | Hematochezia (HP:0002573) | 3.00190818 |
| 29 | Osteolytic defects of the hand bones (HP:0009699) | 2.92852298 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.92852298 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.90672890 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90672890 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.82309057 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67003657 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67003657 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67003657 |
| 37 | Spondylolisthesis (HP:0003302) | 2.65360666 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.63215120 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.60601636 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.58640986 |
| 41 | Polycythemia (HP:0001901) | 2.58184140 |
| 42 | Poikilocytosis (HP:0004447) | 2.57219607 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56902271 |
| 44 | Petechiae (HP:0000967) | 2.55106842 |
| 45 | Stomatitis (HP:0010280) | 2.50387404 |
| 46 | Myositis (HP:0100614) | 2.50060213 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.46420674 |
| 48 | Pustule (HP:0200039) | 2.45994414 |
| 49 | Thrombocytosis (HP:0001894) | 2.45169071 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.44059248 |
| 51 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.41756341 |
| 52 | Joint stiffness (HP:0001387) | 2.41673122 |
| 53 | Premature rupture of membranes (HP:0001788) | 2.41497055 |
| 54 | Peritonitis (HP:0002586) | 2.41397626 |
| 55 | Abnormality of the lumbar spine (HP:0100712) | 2.36255808 |
| 56 | Acanthocytosis (HP:0001927) | 2.35749605 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33142632 |
| 58 | Cellulitis (HP:0100658) | 2.32286918 |
| 59 | Slender build (HP:0001533) | 2.31014536 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.30964218 |
| 61 | Thoracic kyphosis (HP:0002942) | 2.29480670 |
| 62 | Abnormal platelet function (HP:0011869) | 2.28255813 |
| 63 | Impaired platelet aggregation (HP:0003540) | 2.28255813 |
| 64 | Epistaxis (HP:0000421) | 2.27205885 |
| 65 | Follicular hyperkeratosis (HP:0007502) | 2.27000045 |
| 66 | Periodontitis (HP:0000704) | 2.24262274 |
| 67 | Thick nail (HP:0001805) | 2.23860240 |
| 68 | Erythema (HP:0010783) | 2.22876841 |
| 69 | Recurrent skin infections (HP:0001581) | 2.21857865 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20289944 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 2.18198880 |
| 72 | Axonal loss (HP:0003447) | 2.14904652 |
| 73 | Polygenic inheritance (HP:0010982) | 2.14412267 |
| 74 | Purpura (HP:0000979) | 2.12733989 |
| 75 | Increased IgE level (HP:0003212) | 2.12629120 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.10279628 |
| 77 | Colitis (HP:0002583) | 2.10080342 |
| 78 | Facial diplegia (HP:0001349) | 2.09874434 |
| 79 | Disinhibition (HP:0000734) | 2.08522224 |
| 80 | Loss of speech (HP:0002371) | 2.08459324 |
| 81 | Menorrhagia (HP:0000132) | 2.08028630 |
| 82 | Orchitis (HP:0100796) | 2.04844295 |
| 83 | Mitral valve prolapse (HP:0001634) | 2.04235302 |
| 84 | Atrophic scars (HP:0001075) | 2.02466308 |
| 85 | Dyschromatopsia (HP:0007641) | 2.02431973 |
| 86 | Abnormal pupillary function (HP:0007686) | 1.99694713 |
| 87 | Increased serum ferritin (HP:0003281) | 1.99317178 |
| 88 | Beaking of vertebral bodies (HP:0004568) | 1.98291883 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 1.95401166 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 1.93040531 |
| 91 | Gingivitis (HP:0000230) | 1.92749200 |
| 92 | Episodic fever (HP:0001954) | 1.91846723 |
| 93 | Urethral obstruction (HP:0000796) | 1.91741088 |
| 94 | Chest pain (HP:0100749) | 1.90970661 |
| 95 | Type 1 muscle fiber predominance (HP:0003803) | 1.90681823 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 1.89640494 |
| 97 | Spinal rigidity (HP:0003306) | 1.88972431 |
| 98 | Shallow orbits (HP:0000586) | 1.88746331 |
| 99 | Ankle contracture (HP:0006466) | 1.87757577 |
| 100 | Myocardial infarction (HP:0001658) | 1.87389743 |
| 101 | Joint hemorrhage (HP:0005261) | 1.86784555 |
| 102 | Paralysis (HP:0003470) | 1.86228539 |
| 103 | Recurrent fungal infections (HP:0002841) | 1.86130980 |
| 104 | Retinal atrophy (HP:0001105) | 1.84399852 |
| 105 | Increased density of long bones (HP:0006392) | 1.81397126 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80676900 |
| 107 | Arterial thrombosis (HP:0004420) | 1.80023527 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 1.79999602 |
| 109 | Abnormal platelet volume (HP:0011876) | 1.79491377 |
| 110 | Leukocytosis (HP:0001974) | 1.78754539 |
| 111 | Soft skin (HP:0000977) | 1.78725533 |
| 112 | Increased IgM level (HP:0003496) | 1.78566572 |
| 113 | Right ventricular cardiomyopathy (HP:0011663) | 1.78322371 |
| 114 | Abnormality of the thoracic spine (HP:0100711) | 1.77204247 |
| 115 | Basal ganglia calcification (HP:0002135) | 1.75737812 |
| 116 | Mucosal telangiectasiae (HP:0100579) | 1.75522073 |
| 117 | Plantar hyperkeratosis (HP:0007556) | 1.74159821 |
| 118 | Palmoplantar hyperkeratosis (HP:0000972) | 1.74055585 |
| 119 | Chronic otitis media (HP:0000389) | 1.73447419 |
| 120 | Spinal cord lesions (HP:0100561) | 1.73403784 |
| 121 | Syringomyelia (HP:0003396) | 1.73403784 |
| 122 | Pathologic fracture (HP:0002756) | 1.73096524 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 1.72294718 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.72151309 |
| 125 | Gingival bleeding (HP:0000225) | 1.72053017 |
| 126 | Epiphyseal dysplasia (HP:0002656) | 1.70169803 |
| 127 | Mediastinal lymphadenopathy (HP:0100721) | 1.70157414 |
| 128 | Abnormality of the nasal mucosa (HP:0000433) | 1.70062081 |
| 129 | Asymmetric septal hypertrophy (HP:0001670) | 1.68672472 |
| 130 | Bruising susceptibility (HP:0000978) | 1.68529696 |
| 131 | Osteomyelitis (HP:0002754) | 1.68075581 |
| 132 | Short nail (HP:0001799) | 1.67379336 |
| 133 | Obstructive lung disease (HP:0006536) | 1.67353848 |
| 134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.62460893 |
| 135 | Abnormality of the Achilles tendon (HP:0005109) | 1.62260884 |
| 136 | Joint swelling (HP:0001386) | 1.60561459 |
| 137 | Abnormality of lateral ventricle (HP:0030047) | 1.59502785 |
| 138 | Encephalitis (HP:0002383) | 1.59157409 |
| 139 | Vertigo (HP:0002321) | 1.58153614 |
| 140 | Blue sclerae (HP:0000592) | 1.56841169 |
| 141 | Amaurosis fugax (HP:0100576) | 1.55688760 |
| 142 | Cerebral ischemia (HP:0002637) | 1.54847232 |
| 143 | Mitral stenosis (HP:0001718) | 1.54759125 |
| 144 | Urticaria (HP:0001025) | 1.54754319 |
| 145 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.53114831 |
| 146 | Xanthomatosis (HP:0000991) | 1.53015373 |
| 147 | Hypergammaglobulinemia (HP:0010702) | 1.52169504 |
| 148 | Autoimmune hemolytic anemia (HP:0001890) | 1.51757134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.56768552 |
| 2 | ERN1 | 3.00365533 |
| 3 | BLK | 2.77080986 |
| 4 | MAP2K3 | 2.75847457 |
| 5 | EEF2K | 2.51056398 |
| 6 | TRPM7 | 2.34122350 |
| 7 | MST1R | 2.33962205 |
| 8 | CSF1R | 2.16941483 |
| 9 | STK10 | 2.12561387 |
| 10 | PTK2B | 2.12005728 |
| 11 | MAPKAPK3 | 2.07587564 |
| 12 | TRIB3 | 2.02553353 |
| 13 | TYK2 | 1.90424925 |
| 14 | MAP3K3 | 1.90311910 |
| 15 | ZAP70 | 1.78322141 |
| 16 | MAPKAPK5 | 1.77854033 |
| 17 | GRK6 | 1.75380094 |
| 18 | TBK1 | 1.73573706 |
| 19 | IRAK4 | 1.73057393 |
| 20 | PAK4 | 1.72262361 |
| 21 | EIF2AK1 | 1.70020984 |
| 22 | GRK7 | 1.69242329 |
| 23 | MAPK15 | 1.65548232 |
| 24 | TTN | 1.62094055 |
| 25 | IRAK3 | 1.57522147 |
| 26 | PIK3CG | 1.55794349 |
| 27 | PKN2 | 1.54224862 |
| 28 | LRRK2 | 1.51815289 |
| 29 | PIM2 | 1.48082303 |
| 30 | BMPR2 | 1.47158837 |
| 31 | TIE1 | 1.47134977 |
| 32 | CAMK1D | 1.46738877 |
| 33 | GRK5 | 1.44437763 |
| 34 | RPS6KA4 | 1.39539716 |
| 35 | KIT | 1.37897530 |
| 36 | BTK | 1.37892959 |
| 37 | MATK | 1.37816380 |
| 38 | MAP4K1 | 1.36238271 |
| 39 | RPS6KB2 | 1.32452277 |
| 40 | TAOK2 | 1.28245435 |
| 41 | RIPK4 | 1.27191279 |
| 42 | TGFBR1 | 1.26398239 |
| 43 | HCK | 1.26146683 |
| 44 | EPHB1 | 1.23871295 |
| 45 | PTK6 | 1.23085169 |
| 46 | ERBB3 | 1.21801438 |
| 47 | TEC | 1.19761065 |
| 48 | MAP3K6 | 1.17996380 |
| 49 | IKBKB | 1.14936243 |
| 50 | JAK3 | 1.05810773 |
| 51 | MOS | 1.03345055 |
| 52 | CAMKK2 | 1.03167661 |
| 53 | NEK9 | 1.02783042 |
| 54 | CSK | 0.96817391 |
| 55 | MAP3K14 | 0.96359110 |
| 56 | NME2 | 0.95262602 |
| 57 | MAP3K1 | 0.94553752 |
| 58 | MAPKAPK2 | 0.92922077 |
| 59 | CLK1 | 0.92295983 |
| 60 | CDC42BPA | 0.90769314 |
| 61 | PDPK1 | 0.88206874 |
| 62 | PRPF4B | 0.87199545 |
| 63 | PAK1 | 0.86982895 |
| 64 | TNK2 | 0.85024434 |
| 65 | ADRBK1 | 0.85005141 |
| 66 | MAP3K5 | 0.84948640 |
| 67 | IKBKE | 0.84934417 |
| 68 | PDGFRA | 0.81804096 |
| 69 | KDR | 0.81754452 |
| 70 | TAOK1 | 0.80900977 |
| 71 | JAK1 | 0.80601234 |
| 72 | DMPK | 0.80488513 |
| 73 | PDGFRB | 0.80322371 |
| 74 | PDK1 | 0.79946362 |
| 75 | PRKD2 | 0.79625330 |
| 76 | MET | 0.79442142 |
| 77 | ADRBK2 | 0.79030749 |
| 78 | SYK | 0.77380649 |
| 79 | PAK2 | 0.77202634 |
| 80 | TESK2 | 0.75938866 |
| 81 | LYN | 0.75453258 |
| 82 | CDK3 | 0.74524553 |
| 83 | CDK6 | 0.73691901 |
| 84 | FES | 0.73322095 |
| 85 | ITK | 0.72506488 |
| 86 | ARAF | 0.72305182 |
| 87 | RIPK1 | 0.72154265 |
| 88 | DAPK3 | 0.71987439 |
| 89 | STK24 | 0.71166189 |
| 90 | IRAK1 | 0.70983891 |
| 91 | MAP3K13 | 0.70660806 |
| 92 | LCK | 0.69468631 |
| 93 | RET | 0.69371838 |
| 94 | MAPK12 | 0.68074228 |
| 95 | TESK1 | 0.67925447 |
| 96 | PRKD1 | 0.66994092 |
| 97 | DDR2 | 0.64179025 |
| 98 | MST4 | 0.62976894 |
| 99 | MAP2K6 | 0.62716040 |
| 100 | MAPK4 | 0.61411485 |
| 101 | MARK3 | 0.60473480 |
| 102 | TAOK3 | 0.60111244 |
| 103 | IGF1R | 0.60019460 |
| 104 | MYLK | 0.57650967 |
| 105 | TXK | 0.57364115 |
| 106 | BMX | 0.56909480 |
| 107 | JAK2 | 0.55821345 |
| 108 | EPHB2 | 0.55124469 |
| 109 | CAMK1G | 0.54785839 |
| 110 | ILK | 0.53009042 |
| 111 | FER | 0.52163550 |
| 112 | MAPK7 | 0.51860449 |
| 113 | LMTK2 | 0.51507210 |
| 114 | FYN | 0.50592240 |
| 115 | RPS6KA6 | 0.50267184 |
| 116 | EPHA2 | 0.50123087 |
| 117 | ABL2 | 0.49677099 |
| 118 | TSSK6 | 0.49204666 |
| 119 | DYRK1B | 0.48873791 |
| 120 | RPS6KA2 | 0.48374363 |
| 121 | RPS6KC1 | 0.47154150 |
| 122 | RPS6KL1 | 0.47154150 |
| 123 | PRKG2 | 0.47025456 |
| 124 | EGFR | 0.46051140 |
| 125 | EPHA3 | 0.45780407 |
| 126 | MAP2K1 | 0.44678835 |
| 127 | MAP3K11 | 0.44501159 |
| 128 | PTK2 | 0.44231273 |
| 129 | CHUK | 0.43689680 |
| 130 | EIF2AK2 | 0.42937513 |
| 131 | HIPK2 | 0.41704767 |
| 132 | PRKCD | 0.40955091 |
| 133 | PIM1 | 0.39793773 |
| 134 | FGFR3 | 0.39209768 |
| 135 | IRAK2 | 0.38010172 |
| 136 | STK3 | 0.37760729 |
| 137 | FGR | 0.37554435 |
| 138 | CAMKK1 | 0.37260268 |
| 139 | STK4 | 0.36446085 |
| 140 | FLT3 | 0.35902507 |
| 141 | SIK1 | 0.35718400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.51571487 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.94220339 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.22953473 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81589518 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.55230544 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.27160579 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17457612 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.14046009 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.06477397 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98558950 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.76514757 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.75306024 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73574388 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.68319405 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.63820712 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62575190 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.59137040 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57975634 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57819696 |
| 20 | * Platelet activation_Homo sapiens_hsa04611 | 1.56409664 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.53726371 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49227775 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48594142 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46239115 |
| 25 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.44382209 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42995231 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40055558 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.31320020 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.30238976 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.29299009 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26418103 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.24825315 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23908851 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.23857715 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22401240 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20730695 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18215287 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17056300 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.16340954 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14483472 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12397402 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.12062241 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11987317 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.11788945 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11734566 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.10854034 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08173562 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07216570 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.04764859 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02590152 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 1.02576066 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01734377 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.00266610 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99624053 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99330543 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.96420313 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95453412 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92655201 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91717215 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.89697808 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89277513 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87609417 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87241981 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87187795 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87159943 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.83910624 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81765737 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.81440339 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80794856 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75355516 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73295132 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71872564 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69957046 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.68948545 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66898191 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66828733 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66789782 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66303538 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66053240 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65848466 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.64131338 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61327058 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60212692 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60121794 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59974455 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59969361 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59698404 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.58058547 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57490838 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57046254 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56866020 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56222827 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55404203 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54456432 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53200016 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52688859 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52393571 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52325511 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51261352 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51162418 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51055354 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50203675 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.49986794 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49762689 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49230020 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.46136004 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45998949 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45907238 |
| 109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45826144 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45662709 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45180790 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44575177 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.44468806 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43959279 |
| 115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43465740 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42110892 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39607107 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39246954 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38507453 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38222779 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36304099 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35593669 |
| 123 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34942443 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34032009 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32505460 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32226710 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31324790 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31274810 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30663946 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29055032 |

